Biogen remains a financially cheap, unloved Big Pharma name with a number of promising drugs under development. The latest positive readout on LECANEMAB, its second Alzheimer's drug likely to get ...

Biogen employees unwittingly spread the coronavirus from Massachusetts to Indiana, Tennessee and North Carolina. By Farah Stockman and Kim Barker BOSTON — On the first Monday in March, Michel ...

Biogen (BIIB) stock slides after the company issued a weak 2025 outlook. Super Micro Computer (SMCI) shares gain on upbeat long-term outlook despite recent challenges. Stay up to date on the ...

How can Biogen right the ship ... a top Merck executive sees fragility in a ‘super-highway for biomedicine’ 25 million cavities and $9.8 billion: Study estimates the… 25 million cavities ...

Biogen stock was muted Thursday after the biotech company beat Wall Street's first-quarter expectations, including strong sales for newcomer drugs Leqembi and Skyclarys. Leqembi, which partner ...

Biogen’s revenue has been on the decline as the company relies on older products that are losing exclusivity. The acquisition of Reata Pharmaceuticals offers Biogen a new product that could help ...

Biogen has announced it will give up ownership and halt sales of Aduhelm, an embattled Alzheimer's disease drug that was scrutinized following its 2021 approval. Biogen said it terminated a ...

Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow before the bell. Here’s what you need to know. Biogen beat analysts’ revenue expectations by 1.8% last quarter ...

Biogen is officially pivoting away from Aduhelm, the first Alzheimer's treatment the Cambridge drugmaker made. Biogen said over the past year it looked for potential partners or external financing ...

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor ...

Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago. The drugmaker also said Wednesday that it ...

Food For Free, a 501(c)(3) that "rescues" food from places like corporate cafeterias and university dining halls and redistributes it to folks in need, has partnered with Biogen Inc. (Nasdaq ...